Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Collaboration › Details

NLC Ventures–Charles River: drug discovery services, 202204– collab MoU supply early drug discovery + developm services for NLC portfolio companies

 

Period Period 2022-04-20
Organisations Partner, 1st NLC Ventures Netherlands B.V.
  Group NLC Ventures (Group)
  Partner, 2nd Charles River Laboratories International Inc. (NYSE: CRL)
  Group Charles River (Group)
Products Product drug discovery services
  Product 2 drug development services
     

NLC Ventures Netherlands B.V.. (4/20/22). "Press Release: Charles River Laboratories and NLC Collaborate".

NLC – The European Healthtech Venture Builder and Charles River Laboratories team up to drive drug discovery projects towards finding innovative therapeutics.

Charles River Laboratories (“Charles River”) and NLC- The European Healthtech Venture Builder (“NLC”) have signed a Memorandum of Understanding for future collaborations to advance health through early-stage drug discovery and development.

NLC utilises its extensive biotech and pharmaceutical ecosystem and knowledge to carefully select high-potential, preclinical biotech research. Charles River’s comprehensive preclinical development services and strategy resources provide safer, higher-quality drug discovery and development: supporting the projects of NLC’s portfolio companies together to bring life-saving drugs to patients.

Bert-Arjan Millenaar, CEO, NLC, “Our collaboration with Charles River Laboratories will enable preclinical biotech innovations to reach the clinical phase faster with better candidates, eventually improving the lives of millions of people worldwide.”

NLC and Charles River aim to bring the best of European biotech to the patient quicker, better and safer.

   
Record changed: 2022-05-15

Advertisement

Picture [iito] Fighting Customers 650x100px

More documents for NLC Ventures (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top